Hope for thousands of men battling prostate cancer as scientists discover 'practice changing' drug combination that slashes risk of disease returning by 60%

Patients with prostate cancer who were given enzalutamide alongside the standard hormone treatment cut their chances of dying by 58 per cent, found researchers based in the US.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news